Reginald Smith

Title: Reginald Smith: Innovator in Cell Culture Technology

Introduction

Reginald Smith is a notable inventor based in Schenectady, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell culture technology. His innovative work focuses on improving protein titer and cell growth, which are crucial for various applications in the pharmaceutical industry.

Latest Patents

Reginald Smith holds a patent for "Methods of improving protein titer in cell culture." This patent describes methods for enhancing recombinant protein titer and cell titer in cell culture using media that have reduced impurities. The cell culture media, which includes a HEPES buffer, is designed to minimize HEPES-related impurities. The methods and media outlined in the patent aim to improve protein titer, cell growth, and viable cell density.

Career Highlights

Reginald Smith is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in cell culture technology. His work at Regeneron has allowed him to contribute to the development of innovative solutions in the biotechnology sector. With a focus on enhancing the efficiency of protein production, he plays a vital role in advancing the company's research initiatives.

Collaborations

Reginald collaborates with talented coworkers, including Sarah Nicoletti and Victor Shashilov. Their combined efforts contribute to the success of projects aimed at improving cell culture methodologies and enhancing protein production processes.

Conclusion

Reginald Smith's contributions to cell culture technology exemplify the impact of innovation in biotechnology. His patent and work at Regeneron Pharmaceuticals highlight the importance of improving protein titer and cell growth in the industry. Through his efforts, he continues to advance the field and support the development of effective biopharmaceuticals.